Spectator explained German interest in Russian vaccine

Photo of author

By admin

Publicist Konstantin Eckner explained in Spectator magazine why the German authorities are evaluating the possibility of using the Russian Sputnik V coronavirus vaccine.

Political miscalculations and delays in the supply of these drugs are hindering the use of vaccines against infection by pharmaceutical companies Pfizer / BioNTech and Moderna in the EU, according to a material published on February 8.

In addition, European regulators, according to Eckner, are wary of the AstraZeneca vaccine. That is why, according to the conclusions of the publicist, Germany and “may be tempted by the Sputnik V vaccine,” writes Gazeta.ru.

In addition, the author turned to the publication of the results of the Phase III clinical trials of Sputnik V in the medical journal Lancet. An article dated February 2 indicated that the tests had confirmed the high safety of the vaccine. Its efficiency was 91.6%. According to Eckner, this data has become the reason for “violent activity” in Germany.

At the same time, on the day the publicist’s article appeared, official representative of the German Cabinet of Ministers Steffen Seibert said that Germany did not initiate the registration procedure for the Russian Sputnik V vaccine by the national regulator in order to ensure public confidence in the drug.

Earlier it became known that the recent publication of The Lancet magazine about “Sputnik V” made European leaders start talking about its use on their territory, and the German newspaper Die Welt wrote that Russia was able to surprise Western countries with the creation of this vaccine.

Moreover, the Ministry of Health of the Federal Republic of Germany told Izvestia that they are exchanging information with Russia on the development and approval of a vaccine.

Leave a Comment